# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-25-021834
Filing Date
2025-05-02
Accepted
2025-05-02 16:10:22
Documents
95
Period of Report
2025-03-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 1Q25 FORM 10-Q (3.31.25) | mrk-20250331.htm iXBRL | 10-Q | 2001985
2 | EX-31.1 RULE 13A-14(A)/15D-14(A) CERTIFICATION OF CEO | exhibit311-rule13ax14a15dx.htm | EX-31.1 | 8388
3 | EX-31.2 RULE 13A-14(A)/15D-14(A) CERTIFICATION OF CFO | exhibit312-rule13ax14a15dx.htm | EX-31.2 | 8234
4 | EX-32.1 SECTION 1350 CERTIFICATION OF CEO | exhibit321-section1350cert.htm | EX-32.1 | 3867
5 | EX-32.2 SECTION 1350 CERTIFICATION OF CFO | exhibit322-section1350cert.htm | EX-32.2 | 3715
| Complete submission text file | 0001628280-25-021834.txt |  | 12135619

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
6 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | mrk-20250331.xsd | EX-101.SCH | 65998
7 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT | mrk-20250331_cal.xml | EX-101.CAL | 82974
8 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT | mrk-20250331_def.xml | EX-101.DEF | 445714
9 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | mrk-20250331_lab.xml | EX-101.LAB | 768383
10 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | mrk-20250331_pre.xml | EX-101.PRE | 645289
97 | EXTRACTED XBRL INSTANCE DOCUMENT | mrk-20250331_htm.xml | XML | 2562237

Mailing Address 126 EAST LINCOLN AVENUE P.O. BOX 2000 RAHWAY NJ 07065
Business Address 126 EAST LINCOLN AVENUE P.O. BOX 2000 RAHWAY NJ 07065 908-740-4000
Merck & Co., Inc. (Filer) CIK: 0000310158 (see all company filings)

EIN.: 221918501 | State of Incorp.: NJ | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-06571 | Film No.: 25908550
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)